Group One Trading’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.2K Buy
15,553
+15,410
+10,776% +$27.1K ﹤0.01% 5827
2026
Q2
$279 Buy
+143
New +$292 ﹤0.01% 7357
2026
Q1
– Sell
-3,963
Closed -$13.3K – 8124
2025
Q4
$15.8K Buy
+3,963
New +$17.5K ﹤0.01% 6536
2022
Q4
– Sell
-1,974
Closed -$8K – 7627
2022
Q3
$8K Sell
1,974
-23,584
-92% -$179K ﹤0.01% 6629
2022
Q2
$289K Buy
+25,558
New +$306K ﹤0.01% 3940
2021
Q3
– Sell
-156
Closed -$11.3K – 8441
2021
Q2
$13K Buy
+156
New +$10.3K ﹤0.01% 7407

Other funds holding NBP

Group One Trading's NBP Position: Q3 2026 in Review

Group One Trading increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 10,776% in Q3 2026, buying an estimated $27.1K and bringing the position to 15,553 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5827.

Group One Trading first reported a position in NBP in Q2 2021 and has held it in 6 quarters since. The position peaked at $289K in Q2 2022. 48 funds tracked by Wall St. Rank hold NBP as of Q3 2026.

  • Group One Trading held 15,553 shares of NovaBridge Biosciences American Depositary Shares worth $21.2K as of Q3 2026.
  • Group One Trading bought 15,410 NovaBridge Biosciences American Depositary Shares shares in Q3 2026, an estimated $27.1K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5827 holding.
  • Group One Trading first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 6 quarters since.
  • Group One Trading's NovaBridge Biosciences American Depositary Shares position peaked at $289K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.